B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Kaempferol

A group of FLAVONOLS based on kaempferol. They are derived from naringenin and can be hydroxylated to QUERCETIN or reduced to leucopelargonidin.

300 PubMed studies analyzed ยท Evidence Score: 43.3

Research Domains

Kaempferol has been studied across 21 research domains including ๐Ÿ”ฌ Inflammation, ๐Ÿ”ฌ Oncology, ๐Ÿง˜ Stress & Anxiety, โณ Longevity & Aging, ๐Ÿฆด Bone & Joint. The primary research focus is ๐Ÿ”ฌ Inflammation with 28% of studies addressing this area.

Loading evidence profile...

This evidence profile for Kaempferol is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). ยฉ 2026 Organiq Sweden AB.